Rafael Bueno
Physician Assistant · New York, NYNPI 1528114790
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 507 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $6,699 and has fallen 82.9% since, to $1,146 in 2025. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 507 payments — averaging $40.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- AstraZeneca$2K
- Novo Nordisk$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Amgen$1K
- Johnson & Johnson$1K
- plus $10K from 31 others
What the payments were for
- Food & beverage$20,531100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,531 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LofenaDiclofenac Potassium | 13 | $106,543 |
| Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate | 51 | $81,817 |
| JardianceEmpagliflozin | 89 | $68,588 |
| RybelsusSemaglutide | 61 | $66,027 |
| OzempicSemaglutide | 51 | $51,437 |
| LinzessLinaclotide | 81 | $50,022 |
| JanumetSitagliptin Phos/Metformin Hcl | 60 | $45,714 |
| ZtlidoLidocaine | 61 | $41,567 |
| KerendiaFinerenone | 60 | $39,583 |
| FarxigaDapagliflozin Propanediol | 51 | $36,209 |
| XareltoRivaroxaban | 38 | $34,792 |
| VascepaIcosapent Ethyl | 64 | $32,980 |
| JanuviaSitagliptin Phosphate | 37 | $30,909 |
| Doxepin Hcl | 72 | $23,481 |
| TradjentaLinagliptin | 32 | $22,999 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr, Synjardy | $927 | $126,550159 claims |
| Novo NordiskRybelsus, Ozempic | $1,707 | $117,464112 claims |
| MerckJanumet, Januvia | $353 | $76,62397 claims |
| AbbVieLinzess | $2,624 | $50,02281 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $162 | $41,56761 claims |
| BayerKerendia | $1,053 | $39,58360 claims |
| AstraZenecaFarxiga | $2,382 | $36,20951 claims |
| Johnson & JohnsonXarelto | $1,112 | $34,79238 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $616 | $20,57913 claims |
| PfizerEliquis | $123 | $17,65918 claims |
| Mannkind CorporationAfrezza | $260 | $16,88312 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $1,562 | $8,31514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in New York
- Kristyl Cuenca-SiskoNew York$478K
- Cameron KiserNew York$225K
- Mervat FalahNew York$143K
- Marlene TaylorNew York$109K
- Natalie TafelNew York$77K
- Jonathan YehNew York$57K
- Emily ElbogenNew York$49K
- Jaclyn ChurchillNew York$48K
- Russell BrandweinNew York$44K
- Michelle MelchiorreNew York$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.